Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer

Journal of Nutritional Biochemistry

Volumn 20, Issue 8, 2009, Pages 649-655

  Chapkin, Robert S ^a   Kamen, Barton A ^b   Callaway, Evelyn S ^a   Davidson, Laurie A ^a   George, Nysia I ^a   Wang, Naisyin ^a   Lupton, Joanne R ^a   Finnell, Richard H ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Azoxymethane; Dextran sodium sulphate; Folate binding protein; Inflammatory bowel disease; Mouse models; Reduced folate carrier

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; DRINKING WATER; FOLATE BINDING PROTEIN; FOLIC ACID; HOMOCYSTEINE; REDUCED FOLATE CARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; COLITIS; COLON CANCER; CONTROLLED STUDY; ENTERITIS; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC MODEL; HETEROZYGOSITY; HIGH RISK PATIENT; INFLAMMATION; INTESTINE CRYPT; MOUSE; NONHUMAN; TISSUE LEVEL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; AZOXYMETHANE; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; CARCINOGENS; CARRIER PROTEINS; COLITIS; COLONIC NEOPLASMS; DEXTRAN SULFATE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORMULATED; HETEROZYGOTE; HOMOCYSTEINE; INTESTINAL MUCOSA; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NUTRITIONAL STATUS; PRECANCEROUS CONDITIONS; RECEPTORS, CELL SURFACE;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 67649810871     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.07.001     Document Type: Article

References (49)

1. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
2. Itzkowitz S.H., and Yio X. Inflammation and cancer. Colorectal cancer and inflammatory bowel disease: the role of inflammation. Am J Physiol 287 (2004) G7-G17
3. Fernandez-Banares F., Abad-Lucruz A., Xiol X., et al. Vitamin status with inflammatory bowel disease. Am J Gastroenterol 84 (1989) 744-748
4. Biasco G., Zannoni U., Paganelli G.M., et al. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomark Prev 6 (1997) 469-471
5. Lashner B.A., Provencher K.S., Seidner D.L., Knesbeck A., and Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112 (1997) 29-32
6. Chowers Y., Seal B.A., Holland R., Fidder H., Simoni F.B., and Bar-Meir S. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 95 (2000) 3498-3502
7. Nensey Y.M., Arlow F.L., and Majumdar A. Increased responsiveness of colorectal mucosa to carcinogen stimulation and protective role of folic acid. Dig Dis Sci 40 (1995) 396-401
8. Min mouse. Cancer Res 60 (2000) 5434-5440
9. Kim Y.I. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135 (2005) 2703-2709
10. Guruswamy S., Swamy M.V., Choi C.I., Steele V.E., and Rao C.V. S-Adenosyl l-methionine inhibits azoxymethane-induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco-2 cell growth in 3D culture. Int J Cancer 122 (2008) 25-30
11. Terry P., Jain M., Miller A.B., Howe G.R., and Rohan T.W. Dietary intake of folic acid and colorectal cancer risk in a cohort of women. Int J Cancer 97 (2002) 864-867
12. Martinez M.E., Giovannucci E., Jiang R., et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer 119 (2006) 1440-1446
13. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenoma. JAMA 297 (2007) 2351-2359
14. Piedrahita J.A., Oetama B., Bennett G.D., et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23 (1999) 228-232
15. Finnell R.H., Spiegelstein O., Wlodarczyk B., et al. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr 132 (2002) 2457S-2461S
16. Ma D.W.L., Finnell R.H., Davidson L.A., et al. Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65 (2005) 887-897
17. Bosson G. Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell. Br J Biomed Sci 60 (2003) 117-129
18. Kamen B.A., and Smith A.K. A review of folate receptor alpha cycling and methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56 (2004) 1085-1097
19. Ramaekers V.T., Rothenberg S.P., Squeira J.M., et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 352 (2005) 1985-1991
20. Borjel A.K., Yngve A., Sjostrom M., and Nilsson T.K. Novel mutations in the 5′-UTR of the FOLR1 gene. Clin Chem Lab Med 44 (2006) 161-167
21. Le Leu R.K., Young G.P., and McIntosh G.H. Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21 (2000) 2261-2265
22. Emi N., Taylor C.J., Chada L., McGaw J., and Powers H.J. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 37 (2003) 586-590
23. Goh J., and O'Morain C.A. Review article: nutrition and adult inflammatory bowel disease. Aliment Pharmacol Ther 17 (2003) 307-320
24. Walzem R.L., and Clifford A.J. Folate deficiency in rats fed diets containing free amino acids or intact proteins. J Nutr 118 (1988) 1089-1096
25. Neufert C., Becker C., and Neurath M.F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2 (2007) 1998-2004
26. Wirtz S., Neufert C., Weigmann B., and Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2 (2007) 541-546
27. Bottiglieri T. Isocratic high performance liquid chromatographic analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues: the effect of exposure to nitrous oxide. Biomed Chromatogr 4 (1990) 239-241
28. Williams K.T., and Schalinske K.L. New insights into the regulation of methyl group and homocysteine metabolism. J Nutr 137 (2007) 311-314
29. Pretlow T.P., and Pretlow T.G. Mutant KRas in aberrant crypt foci (ACF): initiation of colorectal cancer?. Biochim Biophys Acta 1756 (2005) 83-96
30. Neurath M.F., Finotto S., Fuss I., Boirivant M., Galle P.R., and Strober W. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the question. Trends Immunol 22 (2001) 21-26
31. Mathers J.C. Reversal of DNA hypomethylation by folic acid supplements: possible role in colorectal cancer prevention. Gut 54 (2005) 579-581
32. Greten F.R., Eckmann L., Greten T.F., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
33. Strober W., Fuss I.J., and Blumberg R.S. The immunology of mucosal models of inflammation. Annu Rev Immunol 20 (2002) 495-549
34. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
35. Rubin D.T., and Kavitt R.T. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am 35 (2006) 581-604
36. Matherly L.H., and Goldman I.D. Membrane transport of folates. Vitam Horm 66 (2003) 403-456
37. Zhao R., Russell R.G., Wang Y., et al. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 276 (2001) 10224-10228
38. Taparia S., Gelineau-va Waes J., Rosenquist T.H., and Finnell R.H. Importance of folate- homocysteine homeostasis during early embryonic development. Clin Chem Lab Med 45 (2007) 1717-1727
39. Kamen B.A. Folate receptor-alpha. In: Rao M.S. (Ed). Stem cells and CNS development (2002), Humana Press, Totowa (NJ) 117-135
40. Wollack J.B., Makori B., Ahlawat S., et al. Characterization of folate uptake by choroids plexus epithelial cells in a rat primary culture model. J Neurochem 104 (2008) 1494-1503
41. Sierra E.E., and Goldman I.D. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin Oncol 26 (1999) 11-23
42. Qiu A., Jansen M., Sakaris A., et al. Identification of an intestinal folate transporter and molecular basis for hereditary folate malabsorption. Cell 127 (2006) 917-928
43. Sohn K.J., Stempak J.M., Reid S., Shirwadkar S., Mason J.B., and Kim Y.I. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 24 (2003) 81-90
44. 2-microglobulin-deficient mice. Cancer Epidemiol Biomarkers Prev 12 (2003) 1262-1267
45. Blount B.C., Mack M.M., Wehr C.M., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997) 3290-3295
46. Duthie S.J., and Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 12 (1998) 1491-1497
47. Reidy J.A. Role of deoxyuridine incorporation and DNA repair in the expression of human chromosomal fragile sites. Mutat Res 211 (1988) 215-220
48. Vilpo J.A., and Autio-Harmainen H. Uracil DNA glycosylase and deoxyuridine triphosphatase: studies of activity and subcellular location in human normal and malignant lymphocytes. Scand J Clin Invest 43 (1983) 583-590
49. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007) 1003-1107